Motiv8 Investments’s Thermo Fisher Scientific TMO Stock Holding History

Motiv8 Investments’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$17	Buy	+29	New	+$16.4K	0.01%	404

Other funds holding TMO

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Motiv8 Investments's TMO Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Thermo Fisher Scientific (TMO) in Q4 2025: 29 shares worth $17. The stake represents 0.01% of the portfolio and ranks #404 among its holdings.

2,700 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

Motiv8 Investments held 29 shares of Thermo Fisher Scientific worth $17 as of Q4 2025.
Thermo Fisher Scientific was a new Motiv8 Investments position in Q4 2025.
Thermo Fisher Scientific made up 0.01% of Motiv8 Investments's portfolio in Q4 2025, its #404 holding.
2,700 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.